- Home
- Results news
- Indogulf Cropsciences
- Q1 FY26 results
Indogulf Cropsciences Q1 FY26 results: net profit ₹3.87 crore
Indogulf Cropsciences Limited reported consolidated revenue of ₹189.37 crore and a net profit of ₹3.87 crore for Q1 FY26. Against Q4 FY25, revenue rose 50.0%, while EBITDA fell 52.4% to ₹9.92 crore and the margin declined 11.3 percentage points to 5.2%.
Key points
- Consolidated revenue was ₹189.37 crore in Q1 FY26, up 50.0% from Q4 FY25.
- EBITDA was ₹9.92 crore, down 52.4% from Q4 FY25, while the EBITDA margin declined from 16.5% to 5.2%.
- The company reported a net profit of ₹3.87 crore, down 60.5% from ₹9.80 crore in Q4 FY25.
- Basic EPS was ₹0.80, compared with ₹2.10 in Q4 FY25.
- Standalone revenue was ₹185.14 crore and profit for the period was ₹2.95 crore.
How did Indogulf Cropsciences perform in Q1 FY26?
Indogulf Cropsciences reported consolidated revenue of ₹189.37 crore in Q1 FY26, up 50.0% from ₹126.23 crore in Q4 FY25. EBITDA fell 52.4% to ₹9.92 crore from ₹20.84 crore, and the EBITDA margin declined 11.3 percentage points to 5.2% from 16.5%. Total expenses increased 64.3% to ₹185.67 crore, while cost of materials rose 22.4% to ₹168.08 crore.
Consolidated profit before tax was ₹4.65 crore, down 69.4% from ₹15.19 crore in Q4 FY25. The company reported a net profit of ₹3.87 crore, down 60.5% from ₹9.80 crore, while basic EPS fell from ₹2.10 to ₹0.80. The profit margin declined 5.8 percentage points to 2.0% from 7.8%.
On the standalone basis, revenue was ₹185.14 crore and profit for the period was ₹2.95 crore. The board approved the unaudited standalone and consolidated results for the quarter ended 30 June 2025 on 13 August 2025, following a limited review with an unmodified opinion.
| ₹ crore | Q1 FY26 | Q4 FY25 | QoQ |
|---|---|---|---|
| Revenue from operations | 189.37 | 126.23 | +50.0% |
| Other income | 0.93 | 1.94 | −52.1% |
| Total expenses | 185.67 | 113 | +64.3% |
| EBITDA | 9.92 | 20.84 | −52.4% |
| EBITDA margin | 5.2% | 16.5% | −11.3 pp |
| Profit before tax | 4.65 | 15.19 | −69.4% |
| Tax | 0.78 | 5.39 | −85.5% |
| Net profit | 3.87 | 9.80 | −60.5% |
| EPS (₹) | 0.80 | 2.10 | −61.9% |
EBITDA here is revenue from operations less operating costs (total expenses excluding finance costs and depreciation): before other income and exceptional items. Growth is shown only when both figures are positive. Source: Company's results filing (XBRL).
What did Indogulf Cropsciences' management say?
Management said it was targeting 30-35% revenue growth for FY26, its first explicit annual revenue guidance. It guided Q2 FY26 B2C revenue to ₹180-200 crore and said the quarter’s growth trajectory was 20-25%+ against a Q2 FY25 base of approximately ₹250 crore. Management also expected biologicals and nutrients to grow 30-40% and said EBITDA margins should improve year on year in both percentage and absolute terms.
Management said AGPL and Giraffe were expected to contribute ₹70-80 crore in FY26, while 9 new product launches were targeted to drive 21% of growth. It planned 50-60% capacity expansion from Unit 5 by FY26 end, with capex of approximately ₹77 crore, comprising ₹63 crore CWIP and ₹14 crore for dry flowable, and a payback period of 4-5 years.
Management identified a B2B-heavy Q1 mix, price corrections of 4-5% quarter on quarter and 8-15% in select products, competition from China, weather-related demand fluctuations in export markets, capacity utilisation averaging 50-60%, and tighter global regulatory frameworks as risks. No analyst concerns were recorded for the earnings call.
How did Indogulf Cropsciences shares react?
The filing appeared after market hours. IGCL fell 1.6% after 5 minutes, 2.1% after 15 minutes and 4.2% after 30 minutes from the price when the filing appeared. The stock closed 5.5% lower on the reaction day from its pre-results close.
By the next day’s close, the stock was 7.6% lower from its pre-results close, while the Pesticides & Agrochemicals industry median was down 0.3%; IGCL underperformed the sector by 7.3 percentage points. By the fifth session’s close, the stock was down 3.1% from the pre-results close, against a 0.4% decline for the industry median, an excess-sector move of -2.7 percentage points. No earlier results-day reaction data was available.
| After the filing | Stock | Pesticides & Agrochemicals median |
|---|---|---|
| 5 minutes | −1.6% | |
| 15 minutes | −2.1% | |
| 30 minutes | −4.2% | |
| Reaction day | −5.5% | −1.0% |
| Next day | −7.6% | −0.3% |
| 5 days | −3.1% | −0.4% |
Minutes are measured from the price when the filing appeared; days from the previous close. Source: MarketPing price-reaction measurement.
How did other Pesticides & Agrochemicals companies do?
A total of 24 other Pesticides & Agrochemicals companies filed for the quarter, with a median revenue growth of 21.9%. Seventeen reported higher profit. The data does not specify how many peers grew slower or faster than Indogulf Cropsciences.
| Indogulf Cropsciences revenue growth (YoY) | not comparable |
|---|---|
| Median of 24 other Pesticides & Agrochemicals companies | +21.9% |
| Companies whose net profit rose | 17 of 24 |
Source: Filed results (XBRL) of the industry's companies.
Quick answers
What was Indogulf Cropsciences' revenue in Q1 FY26?
Revenue from operations was ₹189.37 crore (consolidated).
Did Indogulf Cropsciences make a profit in Q1 FY26?
Yes. Net profit was ₹3.87 crore.
What was Indogulf Cropsciences' EPS in Q1 FY26?
Basic earnings per share were ₹0.80.
How did Indogulf Cropsciences shares react to the Q1 FY26 results?
On the reaction day the stock moved −5.5% from the previous close; the median Pesticides & Agrochemicals stock moved −1.0%.
When did Indogulf Cropsciences announce its Q1 FY26 results?
On 24 July 2025, in a filing to the NSE.
Sources
- Board Meeting Intimation for Disclosure Of Audited Financial Results For The Quarter And Financial Year Ended On 31St March 2025 (BSE, 21 July 2025) · PDF
- Outcome of Board Meeting (NSE, 24 July 2025) · PDF
- Outcome of Board Meeting (NSE, 24 July 2025) · PDF
- Results - Financial Year Ended March 31, 2025 (BSE, 25 July 2025) · PDF
- Revised Outcome Of Board Meeting Held On July 24, 2025 (BSE, 25 July 2025) · PDF
- Board Meeting Intimation for Intimation Under Regulation 29(1) Read With Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (BSE, 8 August 2025) · PDF
- Outcome of Board Meeting (NSE, 13 August 2025) · PDF
- Outcome of Board Meeting (NSE, 13 August 2025) · PDF
- The earnings call (19 August 2025)
How this was written: every figure in the tables and charts is calculated from the company’s filed results (XBRL) and MarketPing’s price measurements. The text is drafted with AI from those figures and the filings, and a checker removes any sentence carrying a number it cannot trace to them. How we write these.
This is information, not investment advice. MarketPing does not recommend buying or selling any security.